Acthar Recent News
Andrew Left Challenges Mallinckrodt, Compares Acthar To The EpiPen
Andrew Left Talked Mallinckrodt And Evergrande On Bloomberg This Morning
Allegations Mallinckrodt Is Hiking Acthar Prices Called 'False'
Oppenheimer Calls Mallinckrodt's New Acthar Data 'Impressive,' Despite This Week's Turmoil
Northland Starts Jazz Pharma, Mallinckrodt, Shire With Outperform Ratings
Benzinga Mid-Day Market Update
Questcor Plummets After Aetna Limits Coverage of Company Drug